Rayno Life Sciences Stocks To Watch: ALR, CPHD, QDEL, RGDX

Dec. 03, 2012 6:58 PM ETCPHD, QDEL
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ETF investing, Portfolio Strategy, Long/Short Equity

Contributor Since 2007

Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a Technology Transfer Officer at UCLA. He has a B.S. from Penn State University and an MBA from Rutgers University. His WEB site at www.raygent.com is currently focused in biopharmaceuticals, genomics and clinical diagnostics . Mr. Raynovich has extensive expertise in marketing and product development and provides business development consulting to early stage companies in biotechnology, diagnostics and imaging. The Rayno Life Science Portfolio was published on www.raygent.com and other trade media. Articles have been published on the following topics: Alzheimer Disease,Biomarkers, Genomics,Molecular Diagnostics, Oncology Drugs, Personalized Medicine, Targeted Therapy, Technology Trends, H1N1 and Government Policy on biotechnology. The Life Science Portfolio is up over 80% over a 24 mo. period as of 5/30/14and among the life science portfolio winners are ABAX, ALXN, AMRI, BIIB, CBST, GPRO, ILMN, QDEL,REGN, SGEN, and VPHM.

Rayno Life Sciences Tools and Diagnostics: Alere, Cepheid, Quidel and Response Genetics

All of these stocks are already on our focus list but lately have shown signs of strength.

Look for a firm bottom on Alere (ALR) at $18 and a move over $20.

Cepheid (CPHD) has been added as a new long term buy at $31.5.

Quidel has two news items and recent strength:

Jack Schuler has added positions to 15.3% and the Flu season has an early start.

Response Genetics (OTC:RGDX) has made a big move above base of $1.10:

Emerging Biomarker Diagnostics: BGMD,RGDX,VRML | Raygent.com

Disclosure: I am long ALR, CPHD, OTC:RGDX.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.